Jorge’s current work is focused on the identification and charactetization of new driver genes and therapeutic targets in human cancers by performing transposon- and CRISPR/Cas9-based screens. I am particularly interested in understanding the molecular mechanims driving human prostate cancer progression and identifying new prostate cancer vulnerabilities that can be exploited therapeutically.